BHC · ISSUER CIK 885590
Bausch Health Companies Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Bausch Health Companies Inc. insiders reported $0.00 of open-market purchases and $259K of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$259KInsider selling
−$259KNet open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:46 | Sep 30, 2026 | BHC | Director | A · Grant | $5.83 | +10,720 | 440,962 | +2% | $62K | ||
| Oct 2, 202616:27 | Sep 30, 2026 | BHC | Director | A · Grant | $5.83 | +5,789 | 102,859 | +6% | $34K | ||
| Oct 2, 202616:18 | Sep 30, 2026 | BHC | Director | A · Grant | $5.83 | +1,179 | 316,158 | +0% | $7K | ||
| Aug 20, 202616:33 | Aug 19, 2026 | BHC | President, US Pharma | S · Sell10b5-1 | $7.03 | −36,827 | 334,853 | -10% | −$259K |